These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30591715)

  • 1. The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development.
    Krystal AD; Pizzagalli DA; Mathew SJ; Sanacora G; Keefe R; Song A; Calabrese J; Goddard A; Goodman W; Lisanby SH; Smoski M; Weiner R; Iosifescu D; Nurnberger J; Szabo S; Murrough J; Shekhar A; Potter W
    Nat Rev Drug Discov; 2018 Dec; 18(1):82-84. PubMed ID: 30591715
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia.
    Krystal AD; Pizzagalli DA; Smoski M; Mathew SJ; Nurnberger J; Lisanby SH; Iosifescu D; Murrough JW; Yang H; Weiner RD; Calabrese JR; Sanacora G; Hermes G; Keefe RSE; Song A; Goodman W; Szabo ST; Whitton AE; Gao K; Potter WZ
    Nat Med; 2020 May; 26(5):760-768. PubMed ID: 32231295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NIMH 'Fast-Fail Trials' (FAST) Initiative: Rationale, Promise, and Progress.
    Grabb MC; Hillefors M; Potter WZ
    Pharmaceut Med; 2020 Aug; 34(4):233-245. PubMed ID: 32705569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.
    Grabb MC; Cross AJ; Potter WZ; McCracken JT
    J Clin Psychopharmacol; 2016 Oct; 36(5):419-21. PubMed ID: 27404513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
    Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
    [No Abstract]   [Full Text] [Related]  

  • 6. An NIMH perspective on the use of placebos. National Institute of Mental Health.
    Hyman SE; Shore D
    Biol Psychiatry; 2000 Apr; 47(8):689-91. PubMed ID: 10773173
    [No Abstract]   [Full Text] [Related]  

  • 7. NIMH-funded pragmatic trials: moving on.
    Wang PS; Insel TR
    Neuropsychopharmacology; 2010 Dec; 35(13):2489-90. PubMed ID: 21068745
    [No Abstract]   [Full Text] [Related]  

  • 8. Approaches to multisite clinical trials: the National Institute of Mental Health perspective.
    Lebowitz BD; Vitiello B; Norquist GS
    Schizophr Bull; 2003; 29(1):7-13. PubMed ID: 12908657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIMH during the tenure of Director Herbert Pardes, M.D. (1978-1984): The President's Commission on Mental Health and the reemergence of NIMH's scientific mission.
    Pardes H
    Am J Psychiatry; 1998 Sep; 155(9 Suppl):14-9. PubMed ID: 9736859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health advocates complain about NIMH priority for AIDS. National Institute of Mental Health.
    AIDS Policy Law; 2000 Jan; 15(1):5. PubMed ID: 11367224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anhedonia in the age of RDoC.
    Bedwell JS; Gooding DC; Chan CC; Trachik BJ
    Schizophr Res; 2014 Dec; 160(1-3):226-7. PubMed ID: 25464922
    [No Abstract]   [Full Text] [Related]  

  • 12. The FNIH Biomarkers Consortium embraces the BEST.
    Menetski JP; Austin CP; Brady LS; Eakin G; Leptak C; Meltzer A; Wagner JA
    Nat Rev Drug Discov; 2019 Jul; 18(8):567-568. PubMed ID: 31367046
    [No Abstract]   [Full Text] [Related]  

  • 13. NIMH collaborative research on treatment of depression.
    Klein DF
    Arch Gen Psychiatry; 1990 Jul; 47(7):682-8. PubMed ID: 2163248
    [No Abstract]   [Full Text] [Related]  

  • 14. NIMH to screen studies for science and human risks.
    Marshall E
    Science; 1999 Jan; 283(5401):464-5. PubMed ID: 9988644
    [No Abstract]   [Full Text] [Related]  

  • 15. The NIMH-MATRICS consensus statement on negative symptoms.
    Kirkpatrick B; Fenton WS; Carpenter WT; Marder SR
    Schizophr Bull; 2006 Apr; 32(2):214-9. PubMed ID: 16481659
    [No Abstract]   [Full Text] [Related]  

  • 16. Mood disorders in children and adolescents: an NIMH perspective.
    Hyman SE
    Biol Psychiatry; 2001 Jun; 49(12):962-9. PubMed ID: 11430838
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychiatric nursing: coming of age at NIMH.
    McBride AB
    Hosp Community Psychiatry; 1993 Jan; 44(1):11-2, 15. PubMed ID: 8436354
    [No Abstract]   [Full Text] [Related]  

  • 18. Prominent nurses at NIMH.
    McBride AB
    Hosp Community Psychiatry; 1993 Jun; 44(6):593. PubMed ID: 8514317
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.
    Nugent AC; Iadarola ND; Miller FG; Luckenbaugh DA; Zarate CA
    Lancet Psychiatry; 2016 May; 3(5):436-42. PubMed ID: 26971192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nursing research at NIMH: an update.
    McBride AB; Friedenberg EC; Babich KS; Bush CT
    Arch Psychiatr Nurs; 1992 Apr; 6(2):138-41. PubMed ID: 1596113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.